A
ADM Korea Inc
KOSDAQ:187660
ADM Korea Inc
KOSDAQ:187660
Price:
12 000
KRW
1.78%
Market Closed
Market Cap:
₩665.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ADM Korea Inc
Net Income (Common)
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
ADM Korea Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Net Income (Common)
-₩14.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Net Income (Common)
₩1.8T
|
CAGR 3-Years
31%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Net Income (Common)
-₩13.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-18%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Net Income (Common)
₩55B
|
CAGR 3-Years
45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Net Income (Common)
-₩4.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Net Income (Common)
-₩74.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-25%
|
|
No Stocks Found
ADM Korea Inc
Glance View
ADM Korea, Inc. engages in providing clinical operations. The company is headquartered in Seoul, Seoul. The company went IPO on 2021-06-03. The firm is a contract research organization (CRO) that provides clinical trial related services to pharmaceutical companies and bio ventures. The firm also provides post-marketing research (rPMS) services.
Intrinsic Value
533.57
KRW
Overvaluation 96%
A
See Also
What is ADM Korea Inc's Net Income (Common)?
Net Income (Common)
-14.8B
KRW
-14.8B
KRW
Based on the financial report for Dec 31, 2025, ADM Korea Inc's Net Income (Common) amounts to -14.8B KRW.
What is ADM Korea Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
26%
26%
Over the last year, the Net Income (Common) growth was 26%.
